A bill is quickly advancing in the Senate with bipartisan support to spend $120B on countering China's influence by boosting chip manufacturing, R&D, and more
Context & Ripple Effects
This May 2021 bill is the origin point of the legislative arc the rest of the coverage traces: a bipartisan Senate push to spend $120B on chip manufacturing and R&D to counter China. Over the following 13 months it grew into the Chips and Science Act the Senate passed in July 2022 with $52B+ for chipmakers and tax credits, after the House passed its own $350B America Competes Act in February 2022 — two chambers now negotiating competing versions of the same industrial-policy instinct.
First-order effects
- US chipmakers become direct beneficiaries of a $120B federal pipeline for manufacturing and R&D funding, with the Senate's 64-34 procedural vote later showing the subsidy core can clear the chamber with room to spare.
Second-order effects
- The legislative lag cuts both ways: as Congress spent 13 months reconciling the [[a:981287|House and Senate packages, China's semiconductor industry produced an advanced 7nm chip rivaling those made in Taiwan]], raising the stakes for the final bill's size and speed.
Third-order effects
- If the pattern holds, US-China tech competition settles into a subsidy race on both sides — Washington appropriating tens of billions while Beijing backs domestic equipment mandates and state venture funds — making industrial policy, not free trade, the bipartisan default for semiconductors.
The trend: US semiconductor policy is consolidating from a single bill into a bipartisan industrial-policy apparatus, racing against a Chinese chip buildout that advanced while Congress debated.